Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

BackgroundThe quality of life of patients at all stages of hematological malignancy is greatly affected by the disease and its treatment. There is a wide range of health-related quality of life (HRQoL) issues important to these patients. Any new instrument developed to measure HRQoL of such patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Pushpendra Goswami (Author), Esther N. Oliva (Author), Tatyana Ionova (Author), Roger Else (Author), Jonathan Kell (Author), Adele K. Fielding (Author), Daniel M. Jennings (Author), Marina Karakantza (Author), Saad Al-Ismail (Author), Graham P. Collins (Author), Stewart McConnell (Author), Catherine Langton (Author), Sam Salek (Author)
Format: Book
Published: Frontiers Media S.A., 2020-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items